Key takeaways
- Both are antimuscarinic medicines, but they are distinct products with different labeling.
- A clinician reviews symptoms, urinary retention risk, bowel and eye history, other medicines, and adverse effects.
- An overactive-bladder symptom pattern may need evaluation before medication is appropriate.
How they compare
EDITORIAL GUIDETopicOxybutynin ERoxybutynin chlorideSolifenacinsolifenacin succinate
Medication familyAntimuscarinicAntimuscarinic
Common discussionSelected overactive-bladder symptomsSelected overactive-bladder symptoms
Product formExtended-release oral tabletOral tablet
AccessPrescription requiredPrescription required
DecisionRequires an individual clinician reviewRequires an individual clinician review
Primary sources
Labeling can change. Use the current FDA prescribing information and speak with a licensed clinician or pharmacist before making a treatment decision.